CORCEPT THERAPEUTICS INCORPORATED - COMMON STOCK
57.54
22-11月-24 15:44:58
15 分の遅延
株式
+1.62
+2.90%
本日の幅
56.14 - 57.71
ISIN
N/A
ソース
NASDAQ
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
01 11 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Appoints Monica Tellado as President, Emerging Markets
01 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)
26 10 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
25 10 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
02 8 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
26 7 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
17 7 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
27 6 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
03 5 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
26 4 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Final Results of Tender Offer
05 4 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Preliminary Results of Tender Offer
03 4 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Initiates CATALYST Clinical Trial
28 3 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
06 3 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
28 2 2023 15:05:01 提供 Nasdaq GlobeNewswire
-
14 2 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
13 2 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Provides Miricorilant Clinical Development Update
08 12 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals
08 12 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
03 11 2022 15:05:02 提供 Nasdaq GlobeNewswire